Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, November 10, 2021
C2 PHARMA, a pharmaceutical group established to focus on niche active pharmaceutical ingredients (APIs), has expanded their API product portfolio.
read more
C2 PHARMA has acquired the Digoxin API product portfolio of Polish company, Nobilus Ent, self-developed and inherited from Roche/Galenus Mannheim.
read more
Wednesday, April 24, 2019
BurstIQ and the ITA announced the formation of a Strategic Partnership focused on promoting blockchain, healthcare best practices, and strategic domestic and international initiatives.
read more
Wednesday, March 11, 2020
Burke Therapeutics has signed an exclusive marketing and supply agreement with Coeptis for the U.S. market.
read more
Wednesday, October 11, 2017
BTS Research announced they have been recommended for Full Accreditation at their new headquarters following reviewers' first physical evaluation of the new vivarium.
read more
Wednesday, September 14, 2022
Following their recent expansion into formulation, method and lyo development, Berkshire Sterile Manufacturing (BSM) now offers two new services to assist their clients in their R&D efforts as they head towards clinical development and trials.
read more
BSI, a business improvement and standards company, announced a collaborative partnership with Poseidon, an independent pharmaceutical logistics network, with the objective of bringing greater quality, and certainty to the global distribution of ...
read more
Wednesday, March 17, 2021
Bryant Ranch Prepack is voluntarily recalling in total 47 bottles of Spironolactone tablets to the consumer level.
read more
Wednesday, January 04, 2017
Bruker has announced the acquisition of InVivo Biotech Services GmbH, headquartered in Hennigsdorf, Germany, near Berlin. InVivo Biotech is a molecular biology contract manufacturing organization (CMO), and a leading provider of monoclonal antibodies...
read more
Broughton has launched a new Extractables and Leachables (E&L) testing service.
read more
Thursday, October 07, 2021
Brooks Automation announces Brooks Life Sciences Services and Products businesses will be rebranded under the creation of a new identity – Azenta Life Sciences (“Azenta”). Azenta will bring together our existing portfolio of life sciences products ...
read more
Tuesday, January 26, 2016
Broad Institute Genomic Services has partnered with Takeda Pharmaceutical Company Limited to perform genomic analysis on patient samples from a Phase 3 clinical trial of NINLARO® (ixazomib), an oral proteasome inhibitor that was recently approved by ...
read more
Bristol-Myers Squibb Company has announced that the U.S. Food and Drug Administration (FDA) has approved Opdivo (nivolumab) in combination with Yervoy (ipilimumab) for the treatment of patients with BRAF V600 wild-type and BRAF V600 mutation-positive...
read more
Wednesday, September 16, 2015
Bristol-Myers Squibb Company has announced that the FDA has granted Breakthrough Therapy Designation to Opdivo for the potential indication of advanced or metastatic renal cell carcinoma (RCC).
read more
Bristol-Myers Squibb and QIAGEN signed an agreement to explore the use of NGS technology to develop GEPs as predictive or prognostic tools for use with Bristol-Myers Squibb novel I-O therapies in cancer treatment.
read more